Abstract
Magnetic micro/nanoparticles have great potential to be used in drug delivery and magnetic hyperthermia for cancer therapy. Here we report a novel chemical approach for the fabrication of protein-coated FeNi3 particles for use as thermal therapeutic agents. The particles are composed of metallic FeNi3 cores and coated with bovine serum albumin (BSA). The FeNi3@BSA composite particles demonstrate typical ferromagnetism with saturation magnetization (Ms) about 50emu/g and coercivity 150Oe or so. Due to the encapsulation of protein layer, the FeNi3@BSA composite particles exhibit low toxicity and superior biocompatibility. As-prepared FeNi3@BSA particles demonstrate higher heating efficiency compared with that of superparamagnetic ferrite nanoparticles (NPs).
| Original language | English |
|---|---|
| Pages (from-to) | 168-173 |
| Number of pages | 6 |
| Journal | Colloids and Surfaces A: Physicochemical and Engineering Aspects |
| Volume | 414 |
| DOIs | |
| State | Published - 20 Nov 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Ethanol-induced degeneration
- Hyperthermia
- Magnetic materials
- Protein
Fingerprint
Dive into the research topics of 'Protein-passivated FeNi3 particles with low toxicity and high inductive heating efficiency for thermal therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver